Abstract
Ensuring safe drinking water is one of the top priorities in public health as waterborne diseases remain a global challenge. In China, microbial contamination in drinking water is of particular concern and comprehensive survey/monitoring of the drinking water microbiome is necessary. However, traditional culture-based microbial monitoring methods have significant limitations, and nationwide tap water survey/monitoring in China would require significant resources. Here, a cost-effective and culture-independent citizen science approach was developed to sample the microbiome in household drinking water (n = 50) from 19 provinces in China from December 2020 to August 2021, including a few opportunistic samples collected in situ right after extreme weather events such as the 2021 Henan Floods and Typhoon In-Fa Landfall. Using a protocol optimized for low-biomass samples, 22 out of 50 tap water samples were tested positive for microbial DNA. 16S rRNA gene metabarcoding were conducted on pooled samples, yielding 7,635 Amplicon Sequence Variants (ASVs), which revealed a diverse microbiome in household tap water. Alarmingly, pathogenic bacteria including Mycobacterium spp., Acinetobacter spp., and Legionella spp. were detected in all PCR positive samples. Despite the limited number of samples, a significant number of pathogenic species (e.g., Salmonella enterica) and/or toxin-producing cyanobacteria (e.g., Microcystis spp.) were detected in local tap water samples from Zhengzhou and Changzhou following the 2021 Henan Floods and Typhoon In-Fa Landfall, respectively. Overall, this study underscores the utility of citizen science in enhancing microbial monitoring and informs future public health strategies for water safety.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by Duke Kunshan University (DKU) Summer Research Scholarship, DKU internal funds to Y.L., and startup funds to Y.L. from Texas A&M University Corpus Christi.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This version put more emphasis on the citizen science sampling approach and less on the microbial community structure.
Data Availability
The datasets and sampling protocol (CS) for this study will be deposited to NCBI and Zenodo (10.5281/zenodo.8012153) upon publication. The codes for data analysis are available upon reasonable request to the authors.
Non-standard abbreviations
- RA
- Relative abundance
- CS
- Citizen science sampling protocol and materials
- NC
- Nanchang, Jiangxi
- XA
- Xi’an, Shanxi
- NJ
- Nanjing, Jiangsu
- HZ
- Huizhou, Guangdong
- JN
- Jinan, Shandong
- ZZ
- Zhengzhou, Henan
- CZ
- Changzhou, Jiangsu
- SH
- Shanghai
- ZB
- Zibo, Shandong
- MA
- Macau
- BJ
- Beijing
- TJ
- Tianjin
- CQ
- Chongqing
- LJ
- Lijiang, Yunnan
- LZ
- Lanzhou, Gansu